Profile
Daniel R.
Henderson is the founder of Emergent Travel Health, Inc. He is currently the Chief Executive Officer at Verndari, Inc.
Daniel R. Henderson active positions
| Companies | Position | Start |
|---|---|---|
Verndari, Inc.
 Verndari, Inc. Packaged SoftwareTechnology Services Verndari, Inc. engages in the research and development of proprietary formulation and delivery technology that will allow the firm to create new vaccines. The company is headquartered in Sacramento, CA. | Chief Executive Officer | - |
Former positions of Daniel R. Henderson
| Companies | Position | End |
|---|---|---|
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Verndari, Inc.
Verndari, Inc. Packaged SoftwareTechnology Services Verndari, Inc. engages in the research and development of proprietary formulation and delivery technology that will allow the firm to create new vaccines. The company is headquartered in Sacramento, CA. | Technology Services |
- Stock Market
- Insiders
- Daniel R. Henderson
